Randomised, controlled, multicenter, phase IV study with house dust Mites subcutaneous immunotherapy. Twelve months symptoms and medication scores results in the ALUMITES study

Data de publicación
2014Título da revista
Allergy
Tipo de contido
Publicación de congreso
